Recombinant human IGF-1 alleviates dyslipidemia induced by lactational maternal dietary restriction - Top-Institutions - MDSpire

Recombinant human IGF-1 alleviates dyslipidemia induced by lactational maternal dietary restriction

  • By

  • Xin Liu

  • Yuanyuan Ma

  • Hong Cui

  • Qi Feng

  • June 4, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Diabetes

  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Diabetes

  • #3

    Peking University First Hospital
    Peking University First Hospital

    Beijing, China

    Key Differentiators

    • Endocrinology

  • #4

    Israeli IBD research nucleus (epi-IIRN)
    Israeli IBD research nucleus (epi-IIRN)

    Jerusalem, Israel

    Key Differentiators

    • Endocrinology

Original Source(s)

Recombinant human IGF-1 alleviates dyslipidemia induced by lactational maternal dietary restriction

  • by Xin Liu, Yuanyuan Ma, Hong Cui, Qi Feng

  • June 4, 2026

Related Content

BMI-specific nonlinear associations and threshold effects of the atherogenic index of plasma on incident prediabetes: insights from 100473 Chinese adults

Metabolic Dysregulation and Antibody-Mediated Rejection After Kidney Transplantation: Interacting Mechanisms and Emerging Clinical Strategies

Analysis of pathogen distribution and association with lipid levels in patients with diabetic foot